Cardiovascular outcomes associated with SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus and cancer: a systematic review and meta-analysis.

Diabetol Metab Syndr · 2024 · PMC11110336 · PMID 38773486

Europe PMC DOI

hedged sentence

0.1900

closest p · 3.8× alpha

0.1900

boldest claim

The sentences

showed a trendP = 0.19not close (p > 0.1)

Subgroup analysis restricted to studies with anthracyclines chemotherapy showed a trend for improvement in heart failure hospitalization with low heterogeneity (RR 0.44, 95% CI 0.13–1.5, P = 0.19; I 2 = 12%).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.